Sitara Peroxide Limited reported a net loss of Rs 42.88 million for the quarter ended September 30, 2026
Filed as: Financial Results for the Quarter Ended 30.09.2026
Summary
Sitara Peroxide Limited reported a net loss of Rs 42.88 million for the quarter ended September 30, 2026, with no revenue from contracts with customers, indicating severe financial challenges.
Read the original filingFigures in the filing
| Item | This period | Period before | Change |
|---|---|---|---|
| Net Loss | PKR 42.88 M | PKR 49.53 M | -13.4% |
| Revenue from Contracts with Customers | PKR 0 M | PKR 0 M | — |
| Other Income | PKR 3.74 M | PKR 0.04 M | +8380.9% |
| Administrative Expenses | PKR 59.38 M | PKR 59.34 M | +0.1% |
| Cash and Bank Balances | PKR 1.91 M | PKR 3.88 M | -50.8% |
Amounts are in Pakistani rupees as stated in the filing (M = million, B = billion).
What the filing says
- The company reported a net loss of Rs 42.88 million, an improvement from the prior period's loss of Rs 49.53 million.
- There was no revenue from contracts with customers, highlighting significant operational issues.
- Cash and bank balances decreased to Rs 1.91 million from Rs 3.88 million, indicating liquidity concerns.
Sitara Peroxide Limited (SPL) on Nafa
Last price Rs 48.28 · Chemical · You can own SPL shares from your phone.
More SPL announcements
- NoticeTransmission of Quarterly Report for the Period Ended 30.09.2026
- NoticeAGM RESOLUTIONS
- NoticeBoard Meeting First Quarter 30.09.2026
- NoticeTransmission of Annual Report for the Year Ended 30.06.2026
- NoticeNotice of Annual General Meeting
- Financial resultSitara Peroxide Limited reported a net profit of Rs 147.46 million for the year ended June 30, 2026Filed as: Financial Results for the Year Ended 30.06.2026
Source: Sitara Peroxide Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.